Net profit of Glenmark Pharmaceuticals declined 86.23% to Rs 46.87 crore in the quarter ended June 2025 as against Rs 340.27 crore during the previous quarter ended June 2024. Sales declined 5.09% to Rs 3059.33 crore in the quarter ended June 2025 as against Rs 3223.30 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 3059.33 | 3223.30 | -5 |
| OPM % | 18.98 | 18.25 | - |
| PBDT | 548.73 | 580.12 | -5 |
| PBT | 418.81 | 462.33 | -9 |
| NP | 46.87 | 340.27 | -86 |